Expert Advisory Group on Marketing of Opioids

The Expert Advisory Group on Marketing of Opioids was established to provide Health Canada with input and advice regarding the evidence on the extent, impact, and value of the pharmaceutical industry's marketing and advertising of opioids.

For more detailed information about the role of the Expert Advisory Group, please refer to the Terms of Reference.

Membership

Members of the Expert Advisory Group include, but are not limited to, health professionals, researchers/academia, and regulatory experts with expertise in areas such as pharmaceutical marketing and promotion, opioids, and prescribing behaviour.

The Expert Advisory Group includes four members, ensuring the appropriate representation of expertise and experience, as well as ability to provide focused advice. For more information on Expert Advisory Group members, please refer to:

Meeting Information

Summaries of Expert Advisory Group meetings can be ordered below. The table will be updated regularly.
Meeting Date Objective Order a copy
2018-08-16 To launch the Expert Advisory Group, finalize Terms of Reference, and provide members with background on the Canadian regulatory system and pharmaceutical industry marketing activities.
2018-08-29 To share information with members on the current Canadian regulatory environment, and discuss the potential influence and usefulness of different advertising activities.
2018-09-27 To update members on the Health Canada consultation session at the Opioid Symposium, and seek expert views on other jurisdictions' measures related to transparency and disclosure, including evidence of their effectiveness.
2019-02-12 To update members on Health Canada actions and seek expert views on planned engagement activities and recent research.
2019-04-04 To update members on broader Health Canada actions related to the opioid crisis.
2019-05-23 To update members on Health Canada actions and seek approval on the summary of the committee's findings and advice.
Summary of Findings and Advice: Expert Advisory Group on the Marketing of Opioids
2018-2019 Overall Summary of Findings and Advice: Expert Advisory Group on the Marketing of Opioids

Related Resources

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: